Apollo Stock Analysis

AMEH -  USA Stock  

USD 53.47  1.70  3.08%

The current price rise of Apollo Medical Holdings could raise concerns from stockholders as the firm it trading at a share price of 53.47 on 686,800 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.3. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Apollo Medical partners.
Please continue to Trending Equities.

Search Stock Analysis 

The Apollo Medical stock analysis report makes it easy to digest most publicly released information about Apollo Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Apollo stock analysis module also helps to analyze the Apollo Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Apollo Stock Analysis Notes

About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Apollo Medical Holdings had 1:10 split on the 27th of April 2015. Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company was founded in 1994 and is headquartered in Alhambra, California. Apollo Medical operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 630 people. For more info on Apollo Medical Holdings please contact Warren Hosseinion at 626 282 0288 or go to http://www.apollomed.net.

Apollo Medical Quarterly Cost of Revenue

140.62 MillionShare

Apollo Medical Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Apollo Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Apollo Medical Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Apollo Medical appears to be risky and price may revert if volatility continues
Apollo Medical has a strong financial position based on the latest SEC filings
About 35.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Apollo Medical exotic insider transaction detected

Apollo Medical Holdings Upcoming and Recent Events

Earnings reports are used by Apollo Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Apollo Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report6th of August 2021
Next Earnings Report3rd of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End9th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Apollo Largest EPS Surprises

Earnings surprises can significantly impact Apollo Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Apollo Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Apollo Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Apollo Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Apollo Medical Holdings specific information freely available to individual and institutional investors to make a timely investment decision.
2nd of June 2021
Financial Statements and Exhibits. Other Events
18th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure
5th of May 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
7th of April 2021
Financial Statements and Exhibits. Regulation FD Disclosure
17th of March 2021
Regulation FD Disclosure
11th of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure
10th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
16th of February 2021
Financial Statements and Exhibits. Other Events

Apollo Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Apollo Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apollo Medical Holdings backward and forwards among themselves. Apollo Medical's institutional investor refers to the entity that pools money to purchase Apollo Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares1.5 M40.4 M
Vanguard Group IncCommon Shares1.3 M34.5 M
Ophir Asset Management Pty LtdCommon Shares418.3 K11.2 M
State Street CorpCommon Shares368.4 K10 M
Geode Capital Management LlcCommon Shares340.7 K9.2 M
Northern Trust CorpCommon Shares244.8 K6.6 M
Jpmorgan Chase CoCommon Shares163.2 K4.4 M
Note, although Apollo Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Apollo Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Apollo Medical's market, we take the total number of its shares issued and multiply it by Apollo Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Apollo Profitablity

Apollo Medical's profitability indicators refer to fundamental financial ratios that showcase Apollo Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Apollo Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Apollo Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Apollo Medical's profitability requires more research than a typical breakdown of Apollo Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 5.51 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 14.38 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.14.
Last ReportedProjected for 2021
Return on Average Assets 0.047  0.05 
Return on Average Equity 0.16  0.16 
Return on Invested Capital 0.23  0.25 
Return on Sales 0.15  0.16 

Management Efficiency

The entity has return on total asset (ROA) of 6.51 % which means that it generated profit of $6.51 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 30.34 %, meaning that it created $30.34 on every $100 dollars invested by stockholders. Apollo Medical management efficiency ratios could be used to measure how well apollo medical holdings manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Average Assets is estimated to increase to 0.05. The current Return on Average Equity is estimated to increase to 0.16. Apollo Medical Assets Non Current are most likely to increase significantly in the upcoming years. The last year's value of Assets Non Current was reported at 478.91 Million. The current Asset Turnover is estimated to increase to 0.89, while Goodwill and Intangible Assets are projected to decrease to roughly 264.8 M.
Last ReportedProjected for 2021
Book Value per Share 9.06  9.77 
Enterprise Value over EBIT 10.00  13.37 
Enterprise Value over EBITDA 8.88  10.01 
Price to Book Value 3.00  3.16 
Tangible Assets Book Value per Share 13.45  14.52 
Enterprise Value1.1 B922.4 M
Tangible Asset Value491.4 M530.2 M

Technical Drivers

As of the 19th of June, Apollo Medical shows the Risk Adjusted Performance of 0.2182, mean deviation of 2.25, and Downside Deviation of 3.05. Apollo Medical Holdings technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Apollo Medical Holdings, which can be compared to its rivals. Please confirm Apollo Medical Holdings maximum drawdown, and the relationship between the information ratio and downside variance to decide if Apollo Medical Holdings is priced correctly, providing market reflects its regular price of 53.47 per share. Given that Apollo Medical has jensen alpha of 1.05, we suggest you to validate Apollo Medical Holdings's prevailing market performance to make sure the company can sustain itself at a future point.

Apollo Medical Holdings Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. View also all equity analysis or get more info about mavp overlap studies indicator.

Apollo Medical Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apollo Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apollo Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apollo Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Albert Young 2 days ago via Macroaxis 
Apollo Medical exotic insider transaction detected
Sim Brandon over two weeks ago via Macroaxis 
Payment of 5426 shares by Sim Brandon of Apollo Medical subject to Rule 16b-3
Sim Brandon over a month ago via Macroaxis 
Purchase by Sim Brandon of 1000 shares of Apollo Medical
Allied Physicians Of California A Profession Medical Corp over a month ago via Macroaxis 
Purchase by Allied Physicians Of California A Profession Medical Corp of 100000 shares of Apollo Medical
Kenneth Sim over a month ago via Macroaxis 
Apollo Medical exotic insider transaction detected
Allied Physicians Of California A Profession Medical Corp over a month ago via Macroaxis 
Purchase by Allied Physicians Of California A Profession Medical Corp of 100000 shares of Apollo Medical
Allied Physicians Of California A Profession Medical Corp over two months ago via Macroaxis 
Exercise of in-the-money or at-the-money derivative position by Allied Physicians Of California A Profession Medical Corp of 34158 shares of Apollo Me...
Eric Chin over two months ago via Macroaxis 
Payment of 555 shares by Eric Chin of Apollo Medical subject to Rule 16b-3
Kenneth Sim over two months ago via Macroaxis 
Exercise or conversion by Kenneth Sim of 31756 shares of Apollo Medical subject to Rule 16b-3
Sim Brandon over three months ago via Macroaxis 
Acquisition by Sim Brandon of 59165 shares of Apollo Medical subject to Rule 16b-3
Eric Chin over three months ago via Macroaxis 
Acquisition by Eric Chin of 8606 shares of Apollo Medical subject to Rule 16b-3
Sim Brandon over three months ago via Macroaxis 
Apollo Medical exotic insider transaction detected

Apollo Medical Predictive Daily Indicators

Apollo Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apollo Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Apollo Medical Forecast Models

Apollo Medical time-series forecasting models is one of many Apollo Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apollo Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Apollo Medical Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Apollo Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apollo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Apollo Medical. By using and applying Apollo Stock analysis, traders can create a robust methodology for identifying Apollo entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin 0.18  0.19 
Gross Margin 0.21  0.23 
Profit Margin 0.06  0.06 
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The companys physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Current Apollo Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apollo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apollo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Apollo Medical Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Apollo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apollo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apollo Medical Holdings, talking to its executives and customers, or listening to Apollo conference calls.
Apollo Analyst Advice Details

Apollo Stock Analysis Indicators

Apollo Medical Holdings stock analysis indicators help investors evaluate how Apollo Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Apollo Medical shares will generate the highest return on investment. By understating and applying Apollo Medical stock analysis, traders can identify Apollo Medical position entry and exit signals to maximize returns.
Quick Ratio2.80
Fifty Two Week Low15.11
Revenue Growth-1.10%
Average Daily Volume Last 10 Day1.11M
Shares Short Prior Month370.09k
Average Daily Volume In Three Month217.94k
Earnings Growth46.90%
Shares Percent Shares Out0.92%
Earnings Quarterly Growth49.50%
Gross Margins21.53%
Forward Price Earnings41.77
Short Percent Of Float1.91%
Float Shares22.69M
Fifty Two Week High55.20
Fifty Day Average36.12
Enterprise Value To Ebitda14.32
Two Hundred Day Average26.44
Enterprise Value To Revenue2.06
Please continue to Trending Equities. Note that the Apollo Medical Holdings information on this page should be used as a complementary analysis to other Apollo Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Apollo Medical Stock analysis

When running Apollo Medical Holdings price analysis, check to measure Apollo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apollo Medical is operating at the current time. Most of Apollo Medical's value examination focuses on studying past and present price action to predict the probability of Apollo Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Apollo Medical's price. Additionally, you may evaluate how the addition of Apollo Medical to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
The market value of Apollo Medical Holdings is measured differently than its book value, which is the value of Apollo that is recorded on the company's balance sheet. Investors also form their own opinion of Apollo Medical's value that differs from its market value or its book value, called intrinsic value, which is Apollo Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollo Medical's market value can be influenced by many factors that don't directly affect Apollo Medical Holdings underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollo Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Apollo Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollo Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.